Description of Medical ServiceTesting of asymptomatic individuals of reproductive age, pregnant females (as well as their male reproductive partner) for the presence of a pathogenic heterozygous variant(s) for a clinically significant monogenic disorder in order to ascertain their genetic carrier status, in a panel of genes that would include testing for cystic fibrosis, spinal muscular atrophy and fragile X syndrome.
Description of Medical ConditionTested individuals must have a >10% a priori aggregate personal risk of being a heterozygous genetic carrier of a clinically significant disorder associated with pathogenic or likely pathogenic variants of the genes in the testing panel. The genes included in the panel will depend on the patient’s family history and ethnic heritage/risk, drawn from published, publicly accessible lists of pathogenic genetic variants and associated disorders. Additionally it is requested that cascade testing should be offered to first-degree biological relatives of those found to be a carrier of a recessive pathogenic variant.
Reason for ApplicationNew MBS item
Medical Service TypeInvestigative
Previous Application Number/sNot Applicable
Application FormApplication Form (PDF 1383 KB)
Application Form (Word 355 KB)
Consultation SurveyConsultation Survey (PDF 583 KB)
Consultation Survey (Word 68 KB)
PASC consultation closed
MSAC consultation input must be received by no later than Friday, 10 June 2022 for it to be considered by MSAC at its July 2022 meeting.
For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process
PICO ConfirmationPICO Confirmation (PDF 1667 KB)
PICO Confirmation (Word 800 KB)